Skip to content
Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. technical analysis

ZBHHealthcare Updated daily

Technical analysis of Zimmer Biomet Holdings, Inc. (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.

What is Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. is a medical technology company that designs, manufactures, and markets orthopedic reconstructive products, including knee and hip implants, as well as solutions for sports medicine, trauma, and craniomaxillofacial surgery. The company offers digital and robotic technologies, including the ROSA Robot system for surgical assistance in implant positioning, along with products such as bone cement and surgical instruments. Its products are designed to treat disorders and injuries of bones, joints, and supporting soft tissues, serving orthopedic surgeons, hospitals, and healthcare institutions worldwide.

Description generated automatically from public sources; it may be inaccurate or out of date.

Zimmer Biomet Holdings, Inc.: latest session data

Closing values for September 2, 2026, computed on the last 12 months of prices.

Close99.50 $
Change+0.10%
RSI (14)54.7
MACD1.578
ADX24.9
Volatility (ATR)2.67%
Volume vs 20-avg93%
12-month high102.86 $
12-month low78.91 $

Moving averages

21 sessions

99.29 $

+0.22%

50 sessions

94.61 $

+5.16%

200 sessions

90.94 $

+9.41%

Session levels

s2

96.61

Support

s1

98.01

Support

pivot

100.43

Pivot

r1

101.83

Resistance

r2

104.25

Resistance

How to read it

In the September 2, 2026 session Zimmer Biomet Holdings, Inc. closed higher at 99.50 $, +0.10% versus the previous session.

The price sits above every moving average observed: +0.22% against the 21-session average, +5.16% against the 50 and +9.41% against the 200.

The 14-period RSI reads 54.7, in neutral territory.

MACD stands at 1.578 against a signal line at 1.948: the histogram is negative (−0.370).

ADX reads 24.9, indicating weak directionality.

Levels computed on the latest session place supports at 98.01 and 96.61 $ and resistances at 101.83 and 104.25 $, around a pivot of 100.43.

The average daily range (ATR) is 2.652 $, or 2.67% of price.

Turnover was 1.4M shares, 93% of the 20-session average.

Over the last twelve months the price ranged between 78.91 and 102.86 $, and today stands −3.27% from the period high.

Measures computed on closing prices. They describe the past; they are not forecasts.

Open the full analysis of Zimmer Biomet Holdings, Inc.

Score, Elliott Waves, moving averages and technical indicators — free, no card

If you're not registered we'll ask you to sign in (free), then open the ZBH analysis.

How Montbon’s technical analysis works

Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.

Elliott Waves

Wave counting to frame the price structure.

MTF moving averages

Moving averages across timeframes to read the trend.

0–100 score

A technical summary of the setup, updated daily.

Read the full Montbon Score methodology →

FAQ about Zimmer Biomet Holdings, Inc.

How is Zimmer Biomet Holdings, Inc. analysed technically?

Technical analysis of Zimmer Biomet Holdings, Inc. is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.

Which timeframes are used for Zimmer Biomet Holdings, Inc.?

The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.

What are Elliott Waves applied to Zimmer Biomet Holdings, Inc.?

Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Zimmer Biomet Holdings, Inc. it helps frame the technical structure of the historical chart and is not a forecast.

Other tickers to analyse

Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.

Are you an issuer and want a correction or removal? Write to info@montbon.com.